The mother machine of cell therapy.
Self-controlled industrial platforms and AI-driven flexible biomanufacturing.
What we do
TONGNIAN runs automated starting-material production and AI flexible biomanufacturing — a fully-closed platform from seed to therapy.
Six trademarked EV product lines span respiratory, joint, skin, sleep and precision-delivery programs.
Fully-closed micro-lots at 0.5–5 L: over 99% purity and 95% sample utilization, NMPA and FDA 21 CFR Part 11 aligned.
01.
AI seed intelligence
A 22,554-entry cargo knowledge base scores every seed lot 0–100; only the top 7% enter premium production.
02.
The mother machine
NuoqTFF 1.0 runs TFF+SEC fully closed: 0.5–5 L micro-lots, over 99% foreign-protein removal, recipes compiled to PLC control in seconds.
03.
AI
Standards-grade delivery: national-standard drafting, four team standards, INCI and FDA DMF filings, 4-hour on-site dispensing.
Individualized EV therapy, industrially made –